Opinions do matter in Healthcare: Structured Expert Elicitation – A statistical approach to decision making
Healthcare decision-making is complex, often requiring choices about treatments, technologies, or policies based on limited evidence.
Structured Expert Elicitation (SEE) has emerged as a powerful approach for addressing these gaps by eliciting expert judgments.
Empowering Health technology assessments through Population-adjusted indirect comparisons
As health technology assessment (HTA) becomes increasingly central to healthcare decision-making, population-adjusted indirect comparisons (PAICs) have emerged as critical tools. These methods allow researchers to compare treatments across trials with varying populations, addressing situations where head-to-head comparisons are unavailable or impractical. Here, we will examine the development of PAICs, their role in network meta-analysis (NMA), and the ongoing debates around their application.
From Compassion to Cure: Caregiver’s Quality of Life as a Treatment Success Yardstick in Clinical Trials
In the realm of healthcare, there exists a group of unsung heroes whose influence extends far beyond the walls of hospitals and clinics. These everyday champions, known as caregivers, invest not only their time but also their hearts into the well-being of those they support.
Antimicrobial Resistance: A threat to the world! But, how does the UK’s ‘Netflix-style’ payment model appeal to roll out new antimicrobials and combat AMR?
This blog covers the latest developments in the Antimicrobial Resistance (AMR) space and how the UK’s recently approved ‘Netflix-style’ subscription-based payment model can work as an example to the world to reverse the decline in the antibiotics category.
A brief history of health technology assessment: A historical ride and present story by Prof. Egon Jonsson (Webinar Notes & QnA)
ConnectHEOR hosted a webinar on 18th January 2022 by Professor Egon Jonsson on the topic “A brief history of health technology assessment: A historical ride and present story”. This blog captures the key points of the discussion in the webinar.
Is Pharmaceutical innovation pushing HTA in the UK? The Innovative Medicines Fund, UK
Updated on 30th July 2022 The guidelines for Innovative Medicines Fund (IMF) have been issued by NHS on June 6, 2022. The design of the IMF has been largely drawn on the lines of Cancer Drug Funds (CDF). Along with the guidelines, the responses to engagement on proposals for IMF have been released. This update […]
